Log in

NASDAQ:EKSO - Ekso Bionics Stock Price, Forecast & News

$3.75
+1.21 (+47.66 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$2.25
Now: $3.75
$3.84
50-Day Range
$0.19
MA: $0.41
$2.83
52-Week Range
$2.25
Now: $3.75
$38.25
Volume508,937 shs
Average Volume68,264 shs
Market Capitalization$21.78 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke. The company's Ekso device is primarily used in a hospital and rehabilitation setting. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
Read More
Ekso Bionics logo

Industry, Sector and Symbol

Industry General industrial machinery,
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EKSO
Previous SymbolOTCMKTS:EKSOD
CUSIPN/A
Phone510-984-1761

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.92 million
Book Value$1.17 per share

Profitability

Net Income$-12,130,000.00

Miscellaneous

Employees77
Market Cap$21.78 million
Next Earnings Date5/6/2020 (Estimated)
OptionableNot Optionable

Receive EKSO News and Ratings via Email

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.


Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

How has Ekso Bionics' stock been impacted by COVID-19 (Coronavirus)?

Ekso Bionics' stock was trading at $0.2616 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EKSO shares have increased by 1,333.0% and is now trading at $3.7486. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Ekso Bionics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Ekso Bionics.

When is Ekso Bionics' next earnings date?

Ekso Bionics is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for Ekso Bionics.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings Inc (NASDAQ:EKSO) released its quarterly earnings results on Thursday, February, 27th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.04). The company earned $3.72 million during the quarter. Ekso Bionics had a negative return on equity of 286.13% and a negative net margin of 87.19%. View Ekso Bionics' earnings history.

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Ekso Bionics shares reverse split on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

What guidance has Ekso Bionics issued on next quarter's earnings?

Ekso Bionics updated its FY 2019 Pre-Market earnings guidance on Friday, January, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $13.9-13.9 million, compared to the consensus revenue estimate of $13.77 million.

What price target have analysts set for EKSO?

3 equities research analysts have issued 1 year price targets for Ekso Bionics' stock. Their forecasts range from $1.20 to $8.00. On average, they expect Ekso Bionics' share price to reach $4.03 in the next twelve months. This suggests a possible upside of 7.6% from the stock's current price. View analysts' price targets for Ekso Bionics.

What are Wall Street analysts saying about Ekso Bionics stock?

Here are some recent quotes from research analysts about Ekso Bionics stock:
  • 1. According to Zacks Investment Research, "Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California. " (3/19/2020)
  • 2. Aegis analysts commented, "We think conversion rate is an interesting metric to follow as it is representative of accounts which trialed the Ekso GT via the rental program, and then decided to make the capital commitment, which is significant, at around $130K per Ekso GT." (8/8/2019)

Has Ekso Bionics been receiving favorable news coverage?

News coverage about EKSO stock has trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ekso Bionics earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View the latest news aboutEkso Bionics.

Are investors shorting Ekso Bionics?

Ekso Bionics saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 4,900,300 shares, an increase of 5.8% from the February 27th total of 4,630,000 shares. Based on an average daily volume of 788,300 shares, the short-interest ratio is currently 6.2 days. Currently, 8.0% of the shares of the stock are sold short. View Ekso Bionics' Current Options Chain.

Who are some of Ekso Bionics' key competitors?

What other stocks do shareholders of Ekso Bionics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ekso Bionics investors own include TransEnterix (TRXC), XOMA (XOMA), Infinity Augmented Reality (ALSO), Opko Health (OPK), Editas Medicine (EDIT), NVIDIA (NVDA), Innovative Industrial Properties (IIPR), Canopy Growth (CGC), Uranium Energy (UEC) and Micron Technology (MU).

Who are Ekso Bionics' key executives?

Ekso Bionics' management team includes the following people:
  • Mr. Steven A. Sherman, Exec. Chairman (Age 73)
  • Mr. Jack Peurach, Pres, CEO & Director (Age 53)
  • Mr. John F. Glenn, CFO & Sec. (Age 57)
  • Mr. William Shaw, Chief Commercial Officer (Age 45)
  • Ms. Foon Lim Chwee, Pres of APAC

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

Who are Ekso Bionics' major shareholders?

Ekso Bionics' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (0.15%). View institutional ownership trends for Ekso Bionics.

Which institutional investors are buying Ekso Bionics stock?

EKSO stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC. View insider buying and selling activity for Ekso Bionics.

How do I buy shares of Ekso Bionics?

Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $3.75.

How big of a company is Ekso Bionics?

Ekso Bionics has a market capitalization of $21.78 million and generates $13.92 million in revenue each year. The company earns $-12,130,000.00 in net income (profit) each year or ($3.45) on an earnings per share basis. Ekso Bionics employs 77 workers across the globe. View additional information about Ekso Bionics.

What is Ekso Bionics' official website?

The official website for Ekso Bionics is http://www.eksobionics.com/.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]


MarketBeat Community Rating for Ekso Bionics (NASDAQ EKSO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  288 (Vote Outperform)
Underperform Votes:  243 (Vote Underperform)
Total Votes:  531
MarketBeat's community ratings are surveys of what our community members think about Ekso Bionics and other stocks. Vote "Outperform" if you believe EKSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EKSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel